Discontinuation of Acetylcholinesterase Inhibitor Treatment in the Nursing Home

Blennow, 2006, Alzheimer's disease, The Lancet, 368, 387, 10.1016/S0140-6736(06)69113-7 Hogan, 2008, Diagnosis and treatment of dementia: 5, CMAJ, 179, 1019, 10.1503/cmaj.081103 Raina, 2008, Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline, Ann Int Med, 148, 379, 10.7326/0003-4819-148-5-200803040-00009 Doody, 2001, Practice parameter: management of dementia (an evidence-based review), Neurology, 56, 1154, 10.1212/WNL.56.9.1154 Rabins Hershey Umegaki, 2008, Discontinuation of donepezil for the treatment of Alzheimer's dementia in geriatric practice, Int Psychogeriatr, 20, 800, 10.1017/S1041610208007011 Raskind, 2004, The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial, Arch Neurol, 61, 253, 10.1001/archneur.61.2.252 Feldman, 2001, A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease, Neurology, 57, 613, 10.1212/WNL.57.4.613 Homma, 2008, Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial, Dement Geriatr Cogn Disord, 25, 399, 10.1159/000122961 Feldman, 2005, Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial, Int J Geriatr Psychiatry, 20, 559, 10.1002/gps.1325 Winblad, 2006, Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study, Lancet, 367, 1057, 10.1016/S0140-6736(06)68350-5 Feldman, 2003, Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden, J Am Geriatr Soc, 51, 737, 10.1046/j.1365-2389.2003.51260.x Weschules, 2008, Acetylcholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use among hospice enrollees with a primary diagnosis of dementia, J Palliat Med, 11, 738, 10.1089/jpm.2007.0125 Shega, 2009, Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end stage dementia: a survey of hospice medical directors, J Palliat Med, 12, 779, 10.1089/jpm.2009.0059